Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Research Paper from Dr. Lilge

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Sep 10, 2021 3:27pm

166 Views

Post# 33840981

RE:RE:RE:RE:RE:New Research Paper from Dr. Lilge

ouch

tamarindo1 wrote: Phase 2 timeline as noted is projected.
To treat 100-125 patients in Canada & US 2020-2024. I still think this projected timeline could possibly be accelerated.
Could have BTD by mid-2022. That's what I'm hoping for.

Of course if we go by TLT's past commitment to timelines the grandchildren will have a good laugh reading this bullboard. :-)